Published in
American Association for the Advancement of Science, Science Translational Medicine, 570(12), 2020
DOI: 10.1126/scitranslmed.abb3791
Links
Tools
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis
Journal article published in 2020 by
David M. P. De Oliveira 
,
Lisa Bohlmann ,
Trent Conroy,
Freda E.-C. Jen ,
Arun Everest-Dass ,
Karl A. Hansford ,
Raghu Bolisetti ,
Ibrahim M. El-Deeb ,
Brian M. Forde ,
Minh-Duy Phan ,
Jake A. Lacey ,
Aimee Tan ,
Tania Rivera-Hernandez,
Stephan Brouwer ,
Nadia Keller
and other authors.
,
Lisa Bohlmann ,
Trent Conroy,
Freda E.-C. Jen ,
Arun Everest-Dass ,
Karl A. Hansford ,
Raghu Bolisetti ,
Ibrahim M. El-Deeb ,
Brian M. Forde ,
Minh-Duy Phan ,
Jake A. Lacey ,
Aimee Tan ,
Tania Rivera-Hernandez,
Stephan Brouwer ,
Nadia Keller
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
The hydroxyquinoline analog PBT2 breaks resistance to polymyxin class antibiotics in polymyxin-resistant Gram-negative bacteria.